By Mike Curley ( October 26, 2020, 12:58 PM EDT) -- Pfizer Inc. is asking the Second Circuit not to revive claims by a group of patients alleging its cholesterol drug Lipitor gave them Type 2 diabetes, saying federal preemption and the statute of limitations put the patients in an "inescapable" dilemma....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.